முடுக்குப்பொறி வாழ்க்கை அறிவியல் கூட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முடுக்குப்பொறி வாழ்க்கை அறிவியல் கூட்டாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முடுக்குப்பொறி வாழ்க்கை அறிவியல் கூட்டாளர்கள் Today - Breaking & Trending Today

Zymergen Purchases Lodo Therapeutics


Zymergen Purchases Lodo Therapeutics
Zymergen Inc. has acquired
Lodo Therapeutics Corp. from
Accelerator Life Science Partners, an early-stage life science accelerator and investment firm. The transaction is the third exit from ALSP’s investment fund,
Accelerator Life Science Partners I, in the last year.
Lodo Therapeutics discovered and developed novel therapeutics to address undruggable targets by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA.
“The Lodo Therapeutics metagenomic platform complements Zymergen’s discovery efforts by expanding their natural product discovery capabilities,” said
Sean Brady, cofounder of Lodo Therapeutics. “I am grateful for the support that the ALSP team provided during Lodo’s development and am eager to incorporate our technology into Zymergen’s platform.” ....

Sean Brady , Zymergen Inc , Lodo Therapeutics Corp , Lodo Therapeutics , Accelerator Life Science Partners , Accelerator Life Science , சீன் பிராடி , லோடோ சிகிச்சை கார்ப் , லோடோ சிகிச்சை , முடுக்குப்பொறி வாழ்க்கை அறிவியல் கூட்டாளர்கள் , முடுக்குப்பொறி வாழ்க்கை அறிவியல் ,

Windtree Strengthens Its Board by Appointing Three New Directors


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Windtree Strengthens Its Board by Appointing Three New Directors
February 4, 2021 GMT
Windtree Therapeutics, Inc. - Striving to deliver hope for a lifetime
WARRINGTON, Pa., Feb. 4, 2021 /PRNewswire/ Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointments of Dr. Evan Loh, Ms. Leslie Williams, and Dr. Rob Scott, to its Board of Directors. The appointments are the result of a board composition analysis conducted by the Board, which took into consideration the changing needs of the Company. In connection with the appointments, Mr. John Leone, Mr. Joseph Mahady, and Dr. Brian Schreiber announced their retirement from the Board. Following the changes, the Windtree Board will continue to be comprised of seven di ....

United States , Evan Loh , James Huang , Leslie Williams , John Leone , Brian Schreiber , Joseph Mahady , Dan Geffkin , Bruce Peacock , Rob Scott , Craig Fraser , Renal Drug Advisory Committee , Global Development For Amgen , John Olin School Of Business , College Of Virginia , University Of Iowa , Phrma Research , Prnewswire Windtree Therapeutics Inc , Development Leadership Forum , Ventaira Pharmaceuticals , Washington University , Transcept Pharmaceuticals , Therapeutics Inc , Board Of Directors Eiger Biopharmaceuticals Inc , Ohmeda Inc , University Of Pennsylvania School Medicine ,